Meeting to be held in New York on April 15 hosted by Truist.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CATX:
- Tax Day 2025 IRS Payment: Stocks to Consider Buying With the Refund
- Optimistic Buy Rating for Perspective Therapeutics Amid Strategic Clinical Developments and Strong Financial Position
- Perspective announces first patient dosed in Phase 1/2a trial of 212PbVMT01
- Perspective Therapeutics price target lowered to $10 from $21 at Truist
- Positive Outlook for Perspective Therapeutics Despite Wider Net Loss, Supported by Strong Cash Position and Upcoming Catalysts